BioNote, Inc. (KRX: 377740)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,770.00
-5.00 (-0.10%)
Dec 20, 2024, 9:00 AM KST

BioNote Revenue

BioNote had revenue of 26.45B KRW in the quarter ending September 30, 2024, with 21.75% growth. This brings the company's revenue in the last twelve months to 99.81B, up 9.55% year-over-year. In the year 2023, BioNote had annual revenue of 90.08B, down -81.22%.

Revenue (ttm)
99.81B
Revenue Growth
+9.55%
P/S Ratio
4.88
Revenue / Employee
334.92M
Employees
298
Market Cap
486.81B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202390.08B-389.58B-81.22%
Dec 31, 2022479.66B-142.70B-22.93%
Dec 31, 2021622.36B-9.15B-1.45%
Dec 31, 2020631.50B591.46B1,476.89%
Dec 31, 201940.05B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition